Randomized multicenter phase II trial comparing two schedules of etirinotecan pegol (NKTR-102) in women with recurrent platinum-resistant/refractory epithelial ovarian cancer. (Q30358635)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized multicenter phase II trial comparing two schedules of etirinotecan pegol (NKTR-102) in women with recurrent platinum-resistant/refractory epithelial ovarian cancer. |
scientific article |
Statements
1 reference
Randomized multicenter phase II trial comparing two schedules of etirinotecan pegol (NKTR-102) in women with recurrent platinum-resistant/refractory epithelial ovarian cancer. (English)
1 reference
Ignace B Vergote
1 reference
Agustin Garcia
1 reference
John Micha
1 reference
Charles Pippitt
1 reference
Johanna Bendell
1 reference
Daniel Spitz
1 reference
Nicholas Reed
1 reference
Graham Dark
1 reference
Paula M Fracasso
1 reference
Emad N Ibrahim
1 reference
Vincent A Armenio
1 reference
Linda Duska
1 reference
Chris Poole
1 reference
Christine Gennigens
1 reference
Luc Y Dirix
1 reference
Abraham C F Leung
1 reference
Carol Zhao
1 reference
Raoudha Soufi-Mahjoubi
1 reference
Gordon Rustin
1 reference
30 September 2013
1 reference
1 reference
4060-4066
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference